BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17315786)

  • 1. [Combined induction chemotherapy and radiotherapy in case of undifferentiated carcinoma of nasopharynx tumours (UCNT)].
    Righini ChA; Soriano E; Morel N; Hitter A; Bolla M; Reyt E
    Rev Laryngol Otol Rhinol (Bord); 2006; 127(4):223-8. PubMed ID: 17315786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction polychemotherapy before radiotherapy in carcinoma of the cavum. The experience of the Ibn Rochd-Casablanca Oncology Centre].
    Samlali R; Acharki A; Sahraoui S; Benider A; Kahlain A
    Bull Cancer Radiother; 1996; 83(2):111-4. PubMed ID: 8688217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
    Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
    Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis.
    Lin YS; Lin LC; Lin SW
    Laryngoscope; 2009 Jul; 119(7):1348-52. PubMed ID: 19402154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P; Lee CC; Chen LF
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
    Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
    Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
    Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
    Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of chemotherapy in the treatment of cancer of the cavum (UCNT): apropos of 47 cases].
    Poupart M; Damiano J; Bolot G; Biron P; Caldentey L; Ardiet JM; Pignat JC
    Bull Cancer; 1994 May; 81(5):366-70. PubMed ID: 7538361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P
    Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy.
    Yeh SA; Tang Y; Lui CC; Huang EY
    Jpn J Clin Oncol; 2006 Mar; 36(3):132-6. PubMed ID: 16520357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
    Chen M; Lin S; Zheng W
    Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidural metastasis in nasopharyngeal carcinoma.
    Bagatzounis A; Erakleous E; Michaelides I
    Strahlenther Onkol; 2003 Feb; 179(2):123-8. PubMed ID: 12590324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
    Low WK; Toh ST; Wee J; Fook-Chong SM; Wang DY
    J Clin Oncol; 2006 Apr; 24(12):1904-9. PubMed ID: 16622266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
    Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
    Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy as part of the initial treatment for nasopharyngeal cancer.
    Harrison LB; Pfister DG; Bosl GJ
    Oncology (Williston Park); 1991 Feb; 5(2):67-70;discussion 70-1,74,79 passim. PubMed ID: 1826210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
    Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects.
    Orbach D; Brisse H; Helfre S; Klijanienko J; Bours D; Mosseri V; Rodriguez J
    Pediatr Blood Cancer; 2008 Apr; 50(4):849-53. PubMed ID: 17973328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of primary tongue carcinoma with second primary tongue carcinoma after radiotherapy for nasopharynx cancer].
    Sun CZ; Chen FJ; Zeng ZY; Li QL; Chen YF; Song M
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):938-41. PubMed ID: 17533748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
    Ferrari D; Chiesa F; CodecĂ  C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
    Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.